Marshall Islands

Reimbursed Care Access

The Republic of the Marshall Islands regulates controlled drugs under the Narcotic Drugs (Prohibition and Control) Act 1987 (and later amendments). Psychedelic substances (classic tryptamines, phenethylamines, ibogaine, mescaline, etc.) are treated as prohibited/controlled under the national prohibited drugs framework with no routine medical/reimbursement pathway; ketamine is recognized as a medical anaesthetic agent in clinical practice globally and is controlled domestically but available for legitimate medical/anesthetic uses. There is no publicly documented, reimbursed medical program for psychedelic-assisted therapies (psilocybin, MDMA, DMT, 5‑MeO‑DMT, ibogaine, ayahuasca, mescaline, 2C‑X) in the Marshall Islands as of the latest national legislation sources.